The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Merck/Pfizer: FDA Approves Bavencio (avelumab) for mMCC (2017-03-23)
> Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer > First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FD...
- BASF Licenses CRISPR-Cas9 Technology from Broad Institute (2017-03-22)
> Global licensing agreement to provide improved products in agricultural and industrial applications > Genome editing seen as the next revolution in biotechnology BASF today announced that it has reached a global licensing agreement with the Broad Institut...
- AC Immune Reports 2016 Financial Results (2017-03-17)
> Strong cash position of CHF 152.2 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates > Successful IPO on NASDAQ raised net proceeds of CHF 69.4 million > Important data on crenezumab supporting 60mg/kg dose...
- Lonza Launches New Hepatocytes for ADME-Tox Testing (2017-03-16)
Lonza now offers a comprehensive portfolio of fresh and cryopreserved human and animal hepatocytes for ADME-Tox testing, further strengthening its position as a leader in cell discovery. This expansion of Lonza’s primary cells range is the result of last year’s acq...
- Cevec, Medac and Provecs: Adenoviral Vector Collaboration (2017-03-16)
> Project will cover the entire process from R&D up to manufacturing and clinical development of adenoviral vectors for medac’s oncology products using CEVEC’s proprietary CAP®GT technology > Collaboration is next step in setting CAP®GT as global standard in ade...
- Agena Bioscience Introduces New Lung and Colon Cancer Panels (2017-03-15)
Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon cancers. The UltraSEEK™ Lung and Colon Panels enable detection of mutations as low as 0.1% minor allele frequency (MAF) from circulating tumor ...
- CRISPR Therapeutics/Casebia: Commercial License from MaxCyte (2017-03-14)
CRISPR Therapeutics and Casebia obtain commercial rights to MaxCyte’s cell engineering platform to develop CRISPR/Cas9-based therapies CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for se...
- NeoGenomics and Definiens to Develop Clinical Assays (2017-03-13)
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to de...
- Novartis: FDA Approves Kisqali with Aromatase Inhibitors (2017-03-13)
> Approved based on a first-line Phase III trial that met its primary endpoint of progression-free survival (PFS) at interim analysis due to superior efficacy compared to letrozole alone > At this interim analysis, Kisqali plus letrozole reduced risk of ...
- Forma Therapeutics: Milestone in Boehringer Collaboration (2017-03-13)
FORMA Therapeutics, a clinical-stage and fully integrated discovery and development company, today announced the achievement of a clinical development milestone in their alliance with Boehringer Ingelheim (BI). The partnership focuses on the discovery and developme...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)